SCHEMBL651909

SCHEMBL651909

COC(=O)c1ccc(CN(Cc2c(-c3ccc(OC)cc3)nc(-c3ccccc3)n2CCN(C)C)CC2CCCCC2)cc1OC

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP3A4 P08684 1/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
HSD17B10 Q99714 1/20 0.35
SLC6A9 P48067 2/20 0.34
SLC6A5 Q9Y345 1/20 0.34
AVPR1B P47901 3/20 0.34
P2RX7 Q99572 1/20 0.34
LTC4S Q16873 2/20 0.34
MAPT P10636 2/20 0.33
CACNA1G O43497 1/20 0.33
CHRM5 P08912 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
CRHR1 P34998 1/20 0.33
HDAC1 Q13547 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL648650 0.88 PDK1 (0.35) ALDH1A1KDM4ECYP3A4HPGDALOX15
SCHEMBL651438 0.88 C5AR1 (0.40) AVPR1BMAPTHDAC1MEN1LMNA
SCHEMBL647832 0.82 AGTR1 (0.41) MAPTHDAC1MEN1LMNAKMT2A
SCHEMBL648473 0.82 C5AR1 (0.37) ALDH1A1SLC6A9SLC6A5AVPR1BMAPT
SCHEMBL10289126 0.81 C5AR1 (0.36) ALDH1A1SLC6A9SLC6A5AVPR1BMAPT
SCHEMBL649269 0.81 C5AR1 (0.36) ALDH1A1KDM4EHPGDSLC6A9SLC6A5
SCHEMBL648105 0.80 C5AR1 (0.38) ALDH1A1TSHRSLC6A9SLC6A5AVPR1B
SCHEMBL5225249 0.78 C5AR1 (0.38) ALDH1A1SLC6A9SLC6A5AVPR1BMAPT
SCHEMBL5137557 0.78 C5AR1 (0.42) ALDH1A1KDM4ECYP3A4HPGDTSHR
SCHEMBL5135340 0.78 C5AR1 (0.42) TSHRCASRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
EP-1490044-A4 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORP (US) 2008-04-16 EP disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
EP-1490044-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2004-12-29 EP disclosed
WO-2003084524-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2003-10-16 WO disclosed